This announcement is a separate document:
昭衍新药关于关于收到董事长提议回购公司A股股份暨推动“提质增效重回报”方案的提示性公告
Zhaoyan Pharmaceutical\'s indicative announcement on receiving the chairman\'s proposal to repurchase the company\'s A-share shares and promote a plan to “improve quality, increase efficiency, and focus on return”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.